IDSA Honors 105 Distinguished Physicians, Scientists with FIDSA
IDSA congratulates the distinguished physicians and scientists from the United States and around the world who were elected this year to be Fellows of IDSA.
Fellowship in IDSA honors those who have achieved professional excellence and provided significant service to the profession. “There has never been a more critical nor more exciting time for the field of infectious diseases. From an emerging outbreak of Ebola in the Congo to domestic outbreaks of measles to working tirelessly to solve the mystery of the patients before them, infectious diseases doctors are on the front lines of research and clinical care, keeping us safe from dangerous illness,” said IDSA President Paul Auwaerter, MD, MBA, FIDSA. “The individuals receiving the FIDSA designation have demonstrated that they are true leaders—in their institutions, their communities, and in the field of infectious diseases.”
Check out the individuals who were honored as Fellows of IDSA.
Clinical Case Challenge on Diagnostics and AMR
We call on you to support the “Clinical Case Challenge” – an international challenge highlighting the value of in vitro diagnostics in the fight against AMR.
This challenge invites medical students, trainees, physicians and others worldwide to submit their case studies on this important healthcare topic, thereby increasing open access cases for medical education.
Many medical schools have gaps in clinical diagnostics and antimicrobial resistance (AMR) content. A challenge is proposed to solicit clinical diagnostic and AMR clinical cases through a global call for participation. Clinical diagnostics are tests to aid clinical management and/or guide treatment decisions. The purpose of the challenge is to encourage medical students, trainees, physicians, and others to collect or write clinical cases that could be used in medical education and shared online. The challenge has two types of clinical cases: original cases written specifically for the contest and not published before; adapted cases that have been published elsewhere and tailored for medical education use.
Guidelines for submissions are described below. The final deadline for cases is May 1st, 2018.
bioMérieux is proud to be the sole sponsor of this initiative developed by the International Diagnostics Center and the London School of Hygiene and Tropical Medicine, the main organizer of this contest. Send your clinical case!
Details: http://www.seshglobal.org/Clinical-Case-Challenge
Questions: Contact the challenge coordinator at AMRcasechallenge@gmail.com
Progress in Combating CREs:
See what all the twitter and buzz is about! Check out the latest from ARLG’s own Dr. David van Duin on colistin vs caz-avi:
https://twitter.com/davidantibiotic/status/905367911283302400
https://twitter.com/davidvanduin/status/904830645700055040
https://twitter.com/DICON_duke/status/905940496203169793
Newsletters
January 2019 Newsletter
Read the January 2019 newsletter for a recap of ARLG presentations at IDWeek 2018TM, and learn more about Sarah Doernberg, MD, MAS, of University of California, San Francisco.
September 2018 Newsletter
Check out our September 2018 newsletter for where to connect with your ARLG colleagues at IDWeek 2018TM, find our latest fact sheets, and plain language summaries for patients. In this newsletter, we feature updates from the Gram-Negative Committee and a spotlight on Ephraim Tsalik, MD, PhD, who is the associate director of diagnostics and MASTERMIND protocol.
- ARLG Newsletter - January 2019
- ARLG Newsletter - September 2018
- ARLG Newsletter - June 2018
- ARLG Newsletter - March 2018
- ARLG Newsletter - December 2015
- ARLG Newsletter - November 2015
- ARLG Newsletter - May 2015
- ARLG Newsletter - February 2015
- ARLG Newsletter - December 2014
- ARLG Newsletter - August/September 2014
- ARLG Newsletter - April 2014
- ARLG Newsletter - January 2014
ARLG In News:
NIH-Funded Antibacterial Resistance Leadership Group Details Progress, Challenges, NIAID, March 9, 2017
Report to The President on Combating Antibiotic Resistance, Whitehouse.gov, September 2014
White House references Duke leadership in antibiotic resistance, Duke Medicine News, September 19, 2014
Duke Leadership in Antibiotic Resistance Referenced in New Executive Action, DCRI, September 19, 2014
Fact Sheet: Obama Administration Takes Actions to Combat Antibiotic-Resistant Bacteria, Whitehouse.gov, September 18, 2014
ND4BB: Addressing The Antimicrobial Resistance Crisis, Nature Reviews Microbiology, March 10, 2014
NIAID Leadership Group for a Clinical Research Network on Antibacterial Resistance, NIAID, March 4, 2014
ARLG Research Network Will Target the Problem of Antibacterial Resistance, DCRI, November 8, 2013
Antibiotic Resistance in the News:
Diagnostic developers target antibiotic resistance : Nature News & Comment
Diagnostic developers target antibiotic resistance, Nature.com, October 9, 2015
NIH Funds Nine Antimicrobial Resistance Diagnostics Projects, NIAID, April 9, 2015
Obama battles 'superbugs' with national plan, CNN.com, March 27, 2015
Combating Antibiotic Resistance, FDA, October 14, 2014
National Strategy to Combat Antibiotic-Resistant Bacteria, CDC, September 22, 2014
New Executive Actions to Combat Antibiotic Resistance and Protect Public Health, Whitehouse.gov, September 18, 2014
Executive Order -- Combating Antibiotic-Resistant Bacteria, whitehouse.gov, September 18, 2014
PCAST Releases New Report on Combating Antibiotic Resistance, whitehouse.gov, September 18, 2014
Antimicrobial resistance, WHO, April 2014